Seeyond Ionis Pharmaceuticals Inc Transaction History

Seeyond

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$33.54 - $40.55 $1.14 Million - $1.37 Million	-33,852 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$34.54 - $47.25 $5,215 - $7,134	151 Added 0.45%	33,852 $1.35 Million
Q1 2021 May 14, 2021	BUY	$42.51 - $63.78 $329,750 - $494,741	7,757 Added 29.9%	33,701 $1.52 Million
Q4 2020 Feb 12, 2021	SELL	$45.3 - $60.27 $1.11 Million - $1.48 Million	-24,593 Reduced 48.66%	25,944 $1.47 Million
Q3 2020 Nov 12, 2020	BUY	$47.45 - $62.95 $663,303 - $879,978	13,979 Added 38.24%	50,537 $2.4 Million
Q2 2020 Aug 13, 2020	BUY	$46.85 - $61.05 $1.51 Million - $1.96 Million	32,129 Added 725.42%	36,558 $2.16 Million
Q1 2020 May 14, 2020	SELL	$41.6 - $63.4 $1,414 - $2,155	-34 Reduced 0.76%	4,429 $509,000
Q3 2019 Nov 13, 2019	BUY	$59.06 - $72.15 $156,390 - $191,053	2,648 Added 145.9%	4,463 $267,000
Q2 2019 Aug 13, 2019	BUY	$62.09 - $86.14 $112,693 - $156,344	1,815 New	1,815 $117,000

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Seeyond, based on Form 13F filings with the SEC.

Stay updated on Seeyond with notifications on news.